Найти
Результаты поиска
-
GENETIC MECHANISMS OF RESISTANCE IN THE TREATMENT OF FUNGAL OTITIS
Introduction: Fungal otitis remains one of the most challenging problems in modern otorhinolaryngology due to a high recurrence rate and the development of resistance of causative agents to antimycotic therapy. In recent years, particular attention has been paid to the genetic mechanisms of antifungal resistance, especially among fungi of the genera Candida and Aspergillus. The aim of the present study was to investigate the role of genetic resistance factors in the development of recurrent forms of fungal otitis and their impact on treatment efficacy. Methods: The study included 192 patients with complicated and recurrent otomycosis who were followed over a prolonged period. A comprehensive clinical and mycological analysis was performed, including assessment of species composition of pathogens, recurrence rates, and effectiveness of standard therapy. Results: The presence of non-albicans Candida and aspergillosis-related forms was found to be significantly associated with higher rates of treatment failure and disease recurrence. Analysis of published data and the authors’ own observations suggests a key role of mutations in genes encoding antifungal drug targets, as well as the involvement of efflux pump mechanisms and biofilm formation in the development of antifungal resistance. Conclusion: The obtained results emphasize the necessity of implementing a personalized approach to the treatment of fungal otitis, taking into account the genetic mechanisms of pathogen resistance.